Hosking, D., Lyles, K., Brown, J. P., Fraser, W. D., Miller, P., Curiel, M. D., … Reid, I. R. (2007). Long-term control of bone turnover in paget's disease with zoledronic acid and risedronate (Journal of Bone and Mineral Research (2007) 22, (142-148)). Journal of Bone and Mineral Research, 22(5), 773. https://doi.org/10.1359/jbmr.061001e

Hosking, D., K. Lyles, J. P. Brown, W. D. Fraser, P. Miller, M. D. Curiel, J. P. Devogelaer, et al. “Long-term control of bone turnover in paget's disease with zoledronic acid and risedronate (Journal of Bone and Mineral Research (2007) 22, (142-148)).” Journal of Bone and Mineral Research 22, no. 5 (May 1, 2007): 773. https://doi.org/10.1359/jbmr.061001e.

Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, et al. Long-term control of bone turnover in paget's disease with zoledronic acid and risedronate (Journal of Bone and Mineral Research (2007) 22, (142-148)). Journal of Bone and Mineral Research. 2007 May 1;22(5):773.

Hosking, D., et al. “Long-term control of bone turnover in paget's disease with zoledronic acid and risedronate (Journal of Bone and Mineral Research (2007) 22, (142-148)).” Journal of Bone and Mineral Research, vol. 22, no. 5, May 2007, p. 773. Scopus, doi:10.1359/jbmr.061001e.

Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR. Long-term control of bone turnover in paget's disease with zoledronic acid and risedronate (Journal of Bone and Mineral Research (2007) 22, (142-148)). Journal of Bone and Mineral Research. 2007 May 1;22(5):773.